🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

8 recruiting trials

for Myelofibrosis (PMF)

Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF) NCT06327100Phase 1, Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Ruxolitinib, Tasquinimod Identification of MPN-specific Antigens and Anti-MPN TCRs in Myeloproliferative Neoplasm NCT07590986n/a1 site📍 Brussels Université Catholique de Louvain Ropeginterferon Alfa 2b Plus Ruxolitinib for Myelofibrosis NCT06770842Phase 21 site📍 Hong Kong The University of Hong Kong · Tests: Ropeginterferon alfa-2b (BESREMi®) Reparixin in Patients With Myelofibrosis Myeloproliferative Neoplasms Research Consortium (MPN-RC 120) NCT05835466Phase 29 sites📍 Tampa📍 Atlanta📍 Buffalo Icahn School of Medicine at Mount Sinai · Tests: reparixin A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i) NCT06343805Phase 121 sites📍 Palo Alto📍 Tampa📍 Kansas City Ajax Therapeutics, Inc., a wholly owned subsidiary of Eli L… · Tests: LY5830966 MPN PROGRESSion Registry: Observational Study Tracking Symptoms, Treatments, and Disease Progression in People With Myeloproliferative Neoplasms (MPNs) NCT07362225n/a2 sites📍 Chicago📍 New York MPN Research Foundation A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF) NCT07357727Phase 3148 sites📍 Denver📍 New Haven📍 Fort Myers Novartis Pharmaceuticals · Tests: Pelabresib, Ruxolitinib, Placebo A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms NCT07469891Phase 118 sites📍 Los Angeles📍 Denver📍 Coral Springs Prelude Therapeutics Incorporated · Tests: PRT12396
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy